Cargando…
Use of combinatorial pharmacogenomic testing in two cases from community psychiatry
This report describes two cases in which pharmacogenomic testing was utilized to guide medication selection for difficult to treat patients. The first patient is a 29-year old male with bipolar disorder who had severe akathisia due to his long acting injectable antipsychotic. The second patient is a...
Autores principales: | Fields, Eve S, Lorenz, Raymond A, Winner, Joel G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993396/ https://www.ncbi.nlm.nih.gov/pubmed/27574460 http://dx.doi.org/10.2147/PGPM.S106570 |
Ejemplares similares
-
Combinatorial Versus Individual Gene Pharmacogenomic Testing in Mental Health: A Perspective on Context and Implications on Clinical Utility
por: Winner, Joel G., et al.
Publicado: (2015) -
The clinical validity and utility of combinatorial pharmacogenomics: Enhancing patient outcomes
por: Benitez, Joachim, et al.
Publicado: (2015) -
Pharmacogenomic Biomarkers and Their Applications in Psychiatry
por: Kam, Heejin, et al.
Publicado: (2020) -
Delayed Signs and Symptoms of Extended Release Guanfacine Overdose in Two Adolescent Patients: Implications of Monitoring on the Psychiatry Unit
por: Mishra, Sanskriti, et al.
Publicado: (2022) -
Barriers to clinical adoption of pharmacogenomic testing in psychiatry: a critical analysis
por: Virelli, Catherine R., et al.
Publicado: (2021)